medi4736
Showing 26 - 29 of 29
DLBCL Trial in Worldwide (MEDI4736, tremelimumab, AZD9150)
Completed
- Diffuse Large B-Cell Lymphoma
- MEDI4736
- +2 more
-
La Jolla, California
- +12 more
Feb 26, 2019
Part A and B: Advanced Solid Malignancies, Part C: Malignant Mesothelioma Trial in Japan (Tremelimumab, MEDI4736)
Completed
- Part A and B: Advanced Solid Malignancies
- Part C: Malignant Mesothelioma
- Tremelimumab
- MEDI4736
-
Bunkyo-ku, Japan
- +10 more
Dec 11, 2018
Pancreatic Cancer Trial in Washington, Bronx, New York (MEDI4736, Tremelimumab, Stereotactic Body Radiation Therapy (SBRT))
Withdrawn
- Pancreatic Cancer
- MEDI4736
- +2 more
-
Washington, District of Columbia
- +2 more
Apr 3, 2019
NSCLC, Nonsmall Cell Lung Cancer, Breast Cancer Trial in Saint Louis (MEDI4736)
Terminated
- Non-Small Cell Lung Cancer
- +17 more
- MEDI4736
-
Saint Louis, MissouriWashington University School of Medicine
Oct 11, 2018